Pancreatic cancer prognosis analysis method, system and device based on ferroptosis related genes
An analytical method and technology for pancreatic cancer, applied in the field of medical evaluation, which can solve problems such as poor prognosis and heterogeneity of pancreatic cancer
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment
[0052] Step S1: In June 2021, the data of 182 pancreatic cancer patients were downloaded from the c-Bioportal database (http: / / www.cbioportal.org / ) based on The Cancer Genome Atlas (TCGA), among which Including important clinicopathological data, gene expression and other files of patients. Some patient cases with missing information were deleted as needed; data were standardized and preprocessed; survival status was classified into two categories: 0 for survival and 1 for death. Normal tissue samples are eliminated, and gene expression levels of tumor tissue samples, such as mRNA expression matrix, are retained. But the source of data is not limited to this.
[0053] Step S2: Screening differential genes from the gene expression data.
[0054] The 60 genes related to ferroptosis include: ACSL4, AKR1C1, AKR1C2, AKR1C3, ALOX15, ALOX5, ALOX12, ATP5MC3, CARS, CBS, CD44, CHAC1, CISD1, CS, DPP4, FANCD2, GCLC, GCLM, GLS2, GPX4, GSS, HMGCR, HSPB1, CRYAB, LPCAT3, MT1G, NCOA4, PTGS2, ...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com